Interactive Investor
>>

Aequus Pharmaceuticals Inc (TSX:AQS) Share Price

AQS

Aequus Pharmaceuticals Inc

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Drug Manufacturers - Specialty & Generic

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XTSX

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. Aequus is developing a pipeline of products in neurology and psychiatry. The company's launched and pipeline products are Tacrolimus IR, Vistitan, AQS1304, AQS1303, and others.Aequus Pharmaceuticals Inc is a specialty pharmaceutical company focused on developing and commercializing differentiated products. It offers products like Topiramate XR, Oxcarbazepine XR, Tacrolimus Immediate Release, Vistitan, and other products.

TSX:AQS

CA0076361033

CAD

Loading...

Loading Comparison

Latest AQS News